Breast Cancer Advances in Biology and Therapeutics
John Libbey Eurotext, 1996 - 360 стор.
Contributions from leading authors in the field of clinical and biological breast cancer research constitute these three chapters: predisposition to breast cancer, carcinogenesis, and early breast cancer screening and management; tumour biology and prognostic; and therapeutics aspects of breast cancer. 21st Meeting of the International Association for Breast Cancer Research, Paris, 1996.
Відгуки відвідувачів - Написати рецензію
Не знайдено жодних рецензій.
Psychological aspects of familial breast cancer
paradigms for human breast cancer
Oncogenes and oncosuppressor genes in the prevention and therapy of breast cancer
Molecular basis of human breast epithelial cell transformation
Multiple mechanisms of conjugated linoleic acid in mammary cancer prevention
n3 polyunsaturated fatty acids and breast cancer
Breast cancer screening The scientific basis and the Danish programme
Molecular and clinical aspects of metalloproteases in breast cancer
Signal transduction of prolactin and cytokine receptors
approaches and clinical results
The role of angiogenesis in tumour progression of breast cancer
Why is cathepsin D involved in breast cancer? A 1996 overview
Urokinase plasminogen activator receptor in breast cancer
Mutiparameter analysis of prognostic factors in breast cancer
Clinical circumvention of antioestrogen resistance
Breast cancer screening The relations with the hospitals and sanitary organisations
Breast cancer screening in Canada
from research to policy
diagnosis strategy and decisional trees
Is there now a consensus on the treatment of minimal breast cancer?
High dose sequential chemotherapy in poor prognosis breast cancer patients
In vivo evaluation of docetaxel Taxotere and vinorelbine Navelbine as single
A short history of drug discovery
The detection of micrometastases in the lymph nodes peripheral blood and bone mar
adipose tissue adjuvant advanced breast cancer Advances in biology analysis angiogenesis antigen associated binding Biol biology and therapeutics bone marrow BRCAl breast cancer breast cancer cells breast cancer patients breast cancer screening breast carcinoma Calvo Cancer Res cath-D cathepsin cathepsin D cell lines chemotherapy chromosome Clin Oncol clinical cyclophosphamide cytokines detected disease DMBA docetaxel domain dose doxorubicin effect EGFR endothelial episialin estrogen expression extracellular fibroblasts gene genetic growth factor hormone replacement therapy human breast cancer inhibition inhibitors invasive John Libbey Eurotext levels Magdelenat malignant mammary mammary tumor mammography median metastasis metastatic metastatic breast cancer mice monoclonal antibodies MUC1 mutations Navelbine oncogenes ovarian ovarian cancer overexpression PEA3 peptides plasminogen activator Proc prognostic factors programme proliferation proteases protein receptor response risk of breast studies surgery survival tamoxifen target testing toxicity treatment trial tumor cells uPA-R uPAR VEGF vinorelbine vitro vivo women